The rising threat of illicit amphetamine-type stimulant use among methadone maintenance treatment patients in East Coast Malaysia: a retrospective observational study

References

• World Health Organization. Patterns and consequences of the use of amphetamine-type stimulants (ATS) [Internet]. In: Malhotra B, editor. Technical briefs on Amphetamine-Type Stimulants (ATS). Vol. 1. Philippines: World Helth Organization; 2011. p. 1–6. www.wpro.who.int/sites/mhi
   Google Scholar
• Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee SA, Tyndall M, Wiessing L, Wodak A, Howard J. Meth/Amphetamine use and associated HIV: implications for global policy and public health. Int J Drug Policy [Internet]. 2010;21:347–58. doi:10.1016/j.drugpo.2009.11.007.
   PubMed Web of Science ®Google Scholar
• HRI. Drug-checking services global state of harm reduction 2018 briefing [Internet]. 2018. 1–2 p. www.hri.global
   Google Scholar
• UNODC. Synthetic drugs in East and Southeast Asia. 2020 May. 1–91 p. http://www.unodc.org/southeastasiaandpacific
   Google Scholar
• UNOCD. World drug report: drug use and health consequence. 1st ed. Vienna Austria: United Nation Publication; 2020. 18–24 p.
   Google Scholar
• ASEAN-NARCO. ASEAN drug monitoring report 2017. 1st ed. Bangkok, Thailand: ASEAN Narcotics Cooperation Center; 2018. p. 12–18.
   Google Scholar
• Wang R, Ding Y, Bai H, Duan S, Ye R, Yang Y, Wang J, Tang R, Gao M, He N, et al. Illicit heroin and methamphetamine use among methadone maintenance treatment patients in Dehong Prefecture of Yunnan Province, China. PLoS One. 2015;10:1–11. doi:10.1371/journal.pone.0133431.
   Web of Science ®Google Scholar
• Singh D, Mamat RB, Narayanan S, Vicknasingam B. Prevalence of Amphetamine-Type Stimulants (ATS) use among clients in primary and private Methadone Maintenance Treatment (MMT) program in Kuantan, Malaysia. J Subst Use [Internet]. 2019;24:666–71. doi:10.1080/14659891.2019.1642409.
   Web of Science ®Google Scholar
• Massah O, Moradi A. The prevalence of methamphetamine dependence among Iranian women in methadone maintenance therapy in Tehran, Iran. Iran J Psychiatry. 2018;13:10–14.
   PubMedGoogle Scholar
• Le NT, Khuong QL, Vu TTV, Thai TT, Le HTCH, Dao PT, Le SH, Tieu TTV, Do VD. Prevalence of Amphetamine-Type stimulant use and related factors among methadone maintenance patients in Ho Chi Minh City Vietnam: a cross-sectional study. J Psychoactive Drugs [Internet]. 2021:1–9. doi:10.1080/02791072.2020.1871126.
   Web of Science ®Google Scholar
• Des Jarlais DC, Feelemyer J, Arasteh K, Huong DT, Oanh KTH, Khue PM, Giang HT, Thanh NTT, Moles JP, Vinh VH, et al. The methamphetamine epidemic among persons who inject heroin in Hai Phong, Vietnam. J Subst Abuse Treat. 2021;126:108320. doi:10.1016/j.jsat.2021.108320.
   PubMed Web of Science ®Google Scholar
• Ali N, Aziz SA, Nordin S, Mi NC, Abdullah N, Paranthaman V, Mahmud M, Yee A, Danaee M. Evaluation of methadone treatment in Malaysia: findings from the Malaysian Methadone Treatment Outcome Study (MyTOS). Subst Use Misuse [Internet]. 2018 Jan 28;53:239–48. Health Institute For Public, editor. https://www.tandfonline.com/doi/full/10.1080/10826084.2017.1385630
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi CX, McGoogan JM, Rou K, Zhang F, Wu Z. Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China. Bull World Health Organ [Internet]. 2013;91:93–101. https://pubmed.ncbi.nlm.nih.gov/23554522/
   PubMed Web of Science ®Google Scholar
• Baharom N, Hassan MR, Ali N, Shah SA. Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia. Subst Abus Treat Prev Policy. 2012;7:6–8. doi:10.1186/1747-597X-7-32.
   PubMed Web of Science ®Google Scholar
• Chen W, Xia Y, Hong Y, Hall BJ, Ling L. Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China-A prospective study. Harm Reduct J. 2013;10:1–10. doi:10.1186/1477-7517-10-23.
   PubMed Web of Science ®Google Scholar
• Ghani FA, Ismail L, Aziz N, Tajjudin I, Rashid MAR. Factors associated with good response in methadone therapy in a Malaysian district hospital. Malaysian J Med Heal Sci. 2019;15:14–19.
   Google Scholar
• Chawarski MC, Vicknasingam B, Mazlan M, Schottenfeld RS. Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia. Drug Alcohol Depend [Internet]. 2012;124:177–80. doi:10.1016/j.drugalcdep.2011.12.024.
   PubMed Web of Science ®Google Scholar
• Isa MFM, Guan NC, Rashid RA, Habil MH, Sidi H, Said MA, Sulaiman AH. Sexual behaviour among male methamphetamine and heroin dependents in selected areas in Malaysia. Sains Malaysiana. 2013;42:1819–26. http://eprints.um.edu.my/id/eprint/10972
   Web of Science ®Google Scholar
• McKetin R, Leung J, Stockings E, Huo Y, Foulds J, Lappin JM, Cumming C, Arunogiri S, Young JT, Sara G, et al. Mental health outcomes associated with the use of amphetamines: a systematic review and meta-analysis. EClinicalMedicine [Internet]. 2019;16:81–97. doi:10.1016/j.eclinm.2019.09.014.
   PubMedGoogle Scholar
• Hatim A. Amphetamine type stimulant (ATS) induced psychosis: a rising problems in Malaysia | S |. Malays J Psychiatry. 2008:1–4. https://www.mjpsychiatry.org/index.php/mjp/article/view/34
   Google Scholar
• Baharudin A, Anuar L, Saini S, Bakar OC, Razali R, Jaafar NRN. Psychiatric comorbidity among community-based, treatment seeking opioid dependents in Klang valley. Sains Malaysiana. 2013;42:417–21.
   Web of Science ®Google Scholar
• MA FM. Annual report: Malaysia AIDS 2014. Kuala Lumpur, Malaysia: Malaysian AIDS Council Malaysian AIDS Foundation; 2014.
   Google Scholar
• Ministry of Home Affairs. Malaysia country report on drug issues 2019 [Internet]. 2nd Meeting of the Aipa Advisory Council on Dangerous Drugs (Aipacodd); 2019 Mar 12-15; Chiang Mai, Thailand: AIPA; 369–97 p. https://www.parliament.go.th/ewtadmin/ewt/aipa2019/download/article/AIPACODD/AnnexM-CountryReportofMalaysia.pdf
   Google Scholar
• WHO Regional Office for Western Pacific. Good practices in Asia : effective paradigm shifts towards an improved national response to drugs and HIV/AIDS. 2011. http://www.who.int/hiv/pub/idu/idu_harm_malaysia/en/index.html
   Google Scholar
• CDC. Downloads | Support | Epi InfoTM | CDC [Internet]. 2021. https://www.cdc.gov/epiinfo/support/esp/es_downloads.html%0Ahttps://www.cdc.gov/epiinfo/support/downloads.html
   Google Scholar
• IBM. SPSS Statistics - IBM [Internet]. 2021. https://www.ibm.com/products/spss-statistics%0Ahttps://www.ibm.com/ru-ru/products/spss-statistics
   Google Scholar
• BPFKK MALAYSIA. Garis Panduan Pendispensan Rawatan Terapi Gantian Methadone. J Chem Inf Model. 2019;53:1689–99.
   Google Scholar
• CDC M. Methadone replacement therapy. Vol. 75. 1st ed. Putajaya, Malaysia: Department of Communicsble Disease Sector STD/HIV; 2016.
   Google Scholar
• United Nations Office on Drugs and Crime. TREATNET quality standards. New York: United Nations publication; 2012.
   Google Scholar
• EMCDDA. Addiction EMC for D and D [Internet]. 2021 [accessed 2021 Jul 7]. https://www.emcdda.europa.eu/stats07/DRD/methods
   Google Scholar
• MAHTAS. Clinical practice guidelines management of chronic hepatitis C in adults. Clinical practice guidelines management of chronic hepatitis C in adults. Putrajaya, Kuala Lumpur: Malaysian Health Technology Assessment Section (MaHTAS) Medical; 2019.
   Google Scholar
• Mamat R, Nasrulddin NAA, Yusoff NAM. Continued use of illicit substance among methadone treatment patients in primary health care clinics in East Coast region of Malaysia. Alcohol Treat Q [Internet]. 2020;38:184–98. doi:10.1080/07347324.2019.1672600.
   Web of Science ®Google Scholar
• Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis. 2010;29:1–14. doi:10.1080/10550880903436010.
   PubMed Web of Science ®Google Scholar
• Kennedy AP, Phillips KA, Epstein DH, Reamer DA, Schmittner J, Preston KL. A randomized investigation of methadone doses at or over 100mg/day, combined with contingency management. Drug Alcohol Depend [Internet]. 2013;130:77–84. doi:10.1016/j.drugalcdep.2012.10.025.
   PubMed Web of Science ®Google Scholar
• Alammehrjerdi Z, Ezard N, Dolan K. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern. Asian J Psychiatr [Internet]. 2018;31:49–55. doi:10.1016/j.ajp.2018.01.001.
   PubMed Web of Science ®Google Scholar
• Li L, Sangthong R, Chongsuvivatwong V, McNeil E, Li J. Lifetime multiple substance use pattern among heroin users before entering methadone maintenance treatment clinic in Yunnan, China. Drug Alcohol Rev. 2010;29:420–25. doi:10.1111/j.1465-3362.2009.00168.x.
   PubMed Web of Science ®Google Scholar
• Shen L, Assanangkornchai S, Liu W, Cai L, Li F, Tang S, Shen J, McNeil EB, Chongsuvivatwong V. Influence of social network on drug use among clients of methadone maintenance treatment centers in Kunming, China. PLoS One. 2018;13:1–13. doi:10.1371/journal.pone.0200105.
   Web of Science ®Google Scholar
• Communicable Disease Department. Global hepatitis report, 2017. 1st ed. Geneva, Switzerland: WHO; 2017.
   Google Scholar
• International Harm Reduction. Harm reduction. 7th ed. The Global State of Harm Reduction 2020. London: International Harm Reduction Association; 2020.
   Google Scholar
• Ministry of Health Malaysia. National strategic plan for viral hepatitis B and C: 2019-2023. 1st ed. Putrajaya, Malaysia: Disease Control Division Ministry of Health Malaysia; 2019. 47 p.
   Google Scholar
• White WL, Campbell MD, Spencer RD, Hoffman HA, Crissman B, DuPont RL. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. J Psychoactive Drugs. 2014;46:114–22. doi:10.1080/02791072.2014.901587.
   PubMed Web of Science ®Google Scholar
• Liao DL, Chen PC, Chen CH, Hsieh CJ, Huang YF, Shih WY, Cheng JJS. Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan. J Psychiatr Res [Internet]. 2013;47:1530–34. doi:10.1016/j.jpsychires.2013.07.001.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu N, Shen W, Li L, Zhou W, Xu L. The abuse characteristics of Amphetamine-Type stimulants in patients receiving methadone maintenance treatment and Buprenorphine maintenance treatment. Drug Des Devel Ther. 2021;15:2109–16. doi:10.2147/DDDT.S305226.
   PubMed Web of Science ®Google Scholar
• Meacham MC, Strathdee SA, Rangel G, Armenta RF, Gaines TL, Garfein RS. Prevalence and correlates of heroin–methamphetamine co-injection among persons who inject drugs in San Diego, California, and Tijuana, Baja California, Mexico. J Stud Alcohol Drugs. 2016;77:774–81. doi:10.15288/jsad.2016.77.774.
   PubMed Web of Science ®Google Scholar
• Palmer A, Scott N, Dietze P, Higgs P. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduct J. 2020;17:1–6. doi:10.1186/s12954-020-00360-9.
   PubMed Web of Science ®Google Scholar
• DEA. 2019 National drug threat assessment [Internet]. Drug Enforcement Administration. 2019; United State: Drug Enforcement Administration. https://www.dea.gov/documents/2020/01/30/2019-national-drug-threat-assessment
   Google Scholar
• Affair MM of H. Malaysia country report on drug issues 2019. 2nd Meeting of the Aipa Advisory Council on Dangerous Drugs (Aipacodd); Chiang Mai, Thailand: Malaysia Ministry of Home Affairs; 2019. 369–97 p.
   Google Scholar